Drug application
TERBUTALINE SULFATE (TERBUTALINE SULFATE)
Drugs@FDA ANDA 211832 · TWI PHARMS
Key facts
| Drug name | TERBUTALINE SULFATE |
|---|---|
| Active ingredients | TERBUTALINE SULFATE |
| Application type | ANDA |
| Application number | 211832 |
| Company | TWI PHARMS |
| Dosage forms | TABLET, ORAL |
| Strength | 2.5MG |
| Marketing status | Discontinued |
| TE codes | AB |
| Reference listed drug | No |
| Latest submission status date | Jun 19, 2020 |
At a glance
- 1–9 Submissions
- None Label versions
- 1–9 Products
- 1–9 Therapeutic equivalents
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA applications
Drugs@FDA covers FDA-approved brand-name and generic drugs and therapeutic biologics, with their applications (NDA, ANDA or BLA), products, submissions and labels.